A REVIEW ON CHIKUNGUNYA VIRUS: Epidemiology, Molecular Evolution, Clinical Manifestations, Diagnosis, Therapeutics and Vaccine Development

Read full text Summarise with VIRAT
Authors: Aarti Devi, Yashsavi Bali, Raman Gupta, Shalu Dhiman, Dr Jyoti Gupta, Yashsavi Bali, Raman Gupta, Shalu Dhiman, Jyoti Gupta
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus responsible for recurrent outbreaks characterized by acute febrile illness and chronic debilitating arthralgia. Since its first identification in 1952, CHIKV has re-emerged globally with increased epidemic intensity, particularly after the 2005–2006 Indian Ocean outbreak. Viral genetic evolution, notably the E1:A226V mutation, enhanced vector adaptability and transmission efficiency, contributing to widespread dissemination. Clinically, chikungunya presents with fever, rash, and severe polyarthralgia, with complications including neurological involvement, chronic inflammatory arthritis, and multi-organ dysfunction. Diagnosis relies on serological assays and molecular techniques such as RT-PCR. Currently, management remains supportive, though antiviral strategies and vaccine candidates are under active development. This review comprehensively summarizes the epidemiology, virology, pathogenesis, clinical features, diagnostic approaches, therapeutic strategies, and vaccine progress related to CHIKV, highlighting future research priorities.

Fields of Study & Subjects

Mosquito-borne diseases and control Viral Infections and Vectors Viral Infections and Outbreaks Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN